Abstract
Through the analysis of the transient expression of the luciferase reporter gene in HeLa cells, an evaluation has been made of the transcriptional activity of oestrogens and of selective oestrogen receptor (ER) modulators (SERMs), mediated by the α and β isoforms of the ER, on the epidermal growth factor receptor gene promoter. Oestrogen-activated ERβ presents a lower transcriptional activity compared with ERα, probably due to structural differences in the AF-1 regions of the receptors. Also SERMs induce different responses depending on the receptor isoform bound. Indeed, the phyto-oestrogens, genistein and daidzein, act as weak agonists of the oestrogenic activity via ERα, but as full agonists when bound to ERβ. The synthetic SERM 4OH-tamoxifen, on the other hand, displays an opposite behaviour since it exerts a full agonist action through ERα, but acts as a full antagonist via ERβ. As we have previously shown for ERα, an ERβ/Sp1 functional synergism has also been highlighted, by means of gel mobility shift assays. Moreover, our results show that the sensitivity of target tissues to oestrogens and SERMs can be affected by coexpression of ERs, depending on the formation of appropriate levels of homo- and heterodimers, thus providing a useful approach to predict the effects of hormonal treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K . (1995). Current Protocols in Molecular Biology, unit 9.6.10-9.6.19. Wiley Interscience: New York.
Beato M . (1989). Cell, 56, 335–344.
Bramlett KS, Wu Y and Burris T . (2001). Mol. Endocrinol., 15, 909–922.
Cosman F and Lindsay R . (1999). Endocr. Rev., 20, 418–434.
De Graffenried LA, Hilsenbeck SG and Fuqua SAW . (2002). J. Steroid Biochem. Mol. Biol., 82, 7–18.
De Wet JR, Wood KV, De Luca M, Helinski DR and Subramani S . (1987). Cell, 54, 313–323.
Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C and Safe S . (1999). J. Biol. Chem., 274, 32099–32107.
Enmark E, Pelto-Huikko M, Grandien K, Lagerkrantz S, Lagerkrantz J, Fried G, Nordenskjold M and Gustafsson J-A . (1997). J. Clin. Endocrinol. Metab., 82, 4258–4265.
Evans RM . (1988). Science, 240, 889–895.
Green S, Walter P, Kumar V, Krust A, Bornert J-M, Argos P and Chambon P . (1986). Nature, 320, 134–139.
Hall JM and McDonnell DP . (1999). Endocrinology, 140, 5566–5578.
Hudson LG, Santon JB and Gill GN . (1989). Mol. Endocrinol., 3, 400–408.
Hudson LG, Santon JB, Glass CK and Gill GN . (1990a). Cell, 62, 1165–1175.
Hudson LG, Thompson KL, Xu J and Gill GN . (1990b). Proc. Natl. Acad. Sci. USA, 87, 7536–7540.
Kim K, Thu N, Saville B and Safe S . (2003). Mol. Endocrinol., 17, 804–817.
Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S and Gustafsson J-A . (1997). Endocrinology, 138, 863–870.
Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, Van Der Saag PT, Van Der Burg B and Gustafsson J-A . (1998). Endocrinology, 139, 4252–4263.
Kurzer MS and Xu X . (1997). Annu. Rev. Nutr., 17, 353–381.
Lingham RB, Stancel GM and Loose-Mitchell DS . (1988). Mol. Endocrinol., 2, 230–235.
Maniatis T, Fritsch EF and Sambrook J . (1982). Molecular Cloning: a Laboratory Manual, unit Unit 16.66-16.67. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
Manolagas SC and Kousteni S . (2001). Endocrinology, 142, 2200–2204.
McInerney EM, Weis KE, Sun J, Mosselman S and Katzenellenbogen BS . (1998). Endocrinology, 139, 4513–4522.
Mosselman S, Polman J and Dijkema R . (1996). FEBS Lett., 392, 49–53.
Neal DE, Bennett MK, Hall RR, Marsh C, Abel PD, Sainsbury JRC and Harris AL . (1985). Lancet, 1, 366–368.
Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ and Scanlan TS . (1997). Science, 277, 1508–1510.
Routledge EJ, White R, Parker MG and Sumpter J . (2000). J. Biol. Chem., 275, 35986–35993.
Salvatori L, Ravenna L, Felli MP, Cardillo MR, Russo MA, Frati L, Gulino A and Petrangeli E . (2000). Endocrinology, 141, 2266–2274.
Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson J-A and Safe S . (2000). J. Biol. Chem., 275, 5379–5387.
Schreiber E, Matthias P, Muller MM and Schaffner W . (1989). Nucleic Acids Res., 17, 6419.
Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA and Katzenellenbogen B . (1999). Endocrinology, 140, 800–804.
Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I and Chambon P . (1989). EMBO J., 8, 1981–1986.
Truss M and Beato M . (1993). Endocr. Rev., 14, 459–479.
Van den Wijngaard A, Mulder WR, Dijkema R, Boersma CJC, Mosselman S, van Zoelen EJJ and Olijve W . (2000). Mol. Endocrinol., 14, 623–633.
Weihua Z, Saji S, Makinen S, Cheng G, Jensen EV, Warner M and Gustafsson J-A . (2000). Proc. Natl. Acad. Sci. USA, 97, 5936–5941.
Yarden R, Lauber AH, El-Ashry D and Chrysogelos SA . (1996). Endocrinology, 137, 2739–2747.
Yasui W, Hata J, Yokozaki H, Nakatani H, Ochiai A, Ito H and Tahara E . (1988). Int. J. Cancer, 41, 211–217.
Acknowledgements
This work was supported in part by grants from ADM, Decatur, Illinois, and in part by grants from CNR, Agenzia 2000 C008B98003.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salvatori, L., Pallante, P., Ravenna, L. et al. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER α and β subtypes via an Sp1 site. Oncogene 22, 4875–4881 (2003). https://doi.org/10.1038/sj.onc.1206784
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206784
Keywords
This article is cited by
-
Flavonoid ingredients of Ginkgo biloba leaf extract regulate lipid metabolism through Sp1-mediated carnitine palmitoyltranferase 1A up-regulation
Journal of Biomedical Science (2014)
-
Significance of estrogen receptor subtypes in breast tumorigenesis and progression
Tumor Biology (2014)
-
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter
Breast Cancer Research and Treatment (2012)
-
Inhibition of Neu-Induced Mammary Carcinogenesis in Transgenic Mice Expressing ERΔ3, a Dominant Negative Estrogen Receptor α Variant
Hormones and Cancer (2012)
-
Overcoming endocrine resistance in breast cancer—are signal transduction inhibitors the answer?
Breast Cancer Research and Treatment (2008)